Tan...I would love to keep it to pm's if the rants

Tan...I would love to keep it to pm's if the rants of "experts" didn't attempt to influence new investors. On the OTC new investors in a bio play as this are limited and are not for the faint of heart. I realize we won't be rid of this type of manipulation until we uplist to a national exchange....in the meantime, it's my belief that the endless slamming of either the CEO or dilution fears is counter-productive. If this Company had just hopeful science then I could see a free for all. But as you and I both know, we have proven, documented and quality science behind the Company.
My apologies to all the mods, as they must be frustrated too, having to keep track of the TOU infractions...at the same time we have a venue that keeps bashers at bay yet allows for dd that supports the science behind Amarantus...this Company will pay large dividends to the patient, in the meantime we have to wait...so far so good from my vantage point!